Advent Pharma Limited reported unaudited earnings results for the second quarter and six months ended December 31, 2017. For the quarter, the company has reported its profit after tax of BDT 15.30 million and basic EPS of BDT 0.31 for the three months period ended on 31 December 2017 (October-December, 2017) as against profit after tax of BDT 10.00 million and basic EPS of BDT 0.58 for the same period of the previous year. For the six months, the company’s basic EPS would be BDT 0.46 for six months period ended on 31 December 2017, (July-December, 2017) and NAV per share would be BDT 12.20 as on 31 December, 2017. Profit after tax was BDT 31.65 million and basic EPS was BDT 0.65 as against profit after tax of BDT 17.99 million and basic EPS of BDT 1.05 for the same period of the previous year.